A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: Prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies

British Journal of Haematology

Volumn 93, Issue 1, 1996, Pages 131-138

  Cavazzana Calvo, M ^a   Bordigoni, P ^b   Michel, G ^c   Esperou, H ^d   Souillet, G ^e   Leblanc, T ^d   Stephan, J L ^f   Vannier, J P ^g   Mechinaud, F ^h   Reiffers, J ⁱ   Vilmer, E ^j   Landman Parker, J ^k   Benkerrou, M ^a   Baruchel, A ^d   Pico, J ^l   Bernaudin, F ^m   Bergeron, C ⁿ   Plouvier, E ^o   Thomas, C ^a   Wijdenes, J ^o   Lacour, B ^b   Blanche, S ^a   Fischer, A ^a   more..

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c TIMONE HOSPITAL   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f Hop Pediat de Saint Etienne ^*

^g ROUEN UNIVERSITY HOSPITAL   (France)

^h NANTES UNIVERSITY HOSPITAL   (France)

ⁱ BORDEAUX UNIVERSITY HOSPITAL   (France)

^j HÔPITAL ROBERT DEBRÉ   (France)

^k ARMAND TROUSSEAU HOSPITAL   (France)

^l INSTITUT GUSTAVE ROUSSY   (France)

^m HENRI MONDOR HOSPITAL   (France)

ⁿ RENNES UNIVERSITY HOSPITAL   (France)

^o Hôpital Diaclone   (France)

more..

Author keywords

adhesion molecules; graft rejection; high risk acute lymphoblastic leukaemia; incompatible bone marrow transplantation; monoclonal antibodies

Indexed keywords

CYTARABINE; LFA 1 ANTIBODY; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MONOCLONAL ANTIBODY CD 2; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GRAFT REJECTION; HUMAN; INFANT; MALE; MULTICENTER STUDY; PRIORITY JOURNAL;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD2; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE;

EID: 9244225193     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.4831024.x     Document Type: Article

References (43)

1. Aversa, F., Tabilio, A., Terenzi, A., Velardi, A., Falzetti, F., Giannoni, C., Jacucci, R., Zei, T., Martelli, M.P., Gambelunghe, C., Rossetti, M., Caputo, P.F., Latini, P., Aristei, C., Raymondi, C., Reisner, Y. & Martelli, M. (1994) Successful engraftment of T-cell-depleted haploidentical 'three loci' incompatible transplants in leukemia patients by adding of recombinant human granulocyte colony-stimulating factor: mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood, 84, 3948-3955.
2. Barrett, J.A., Horowitz, M.M., Pollock, B.H., Zhang, M.J., Bortin, M.M., Buchanan, G.R., Camitta, B.M., Ochs, J., Graham-Pole, J., Rowlings, P.A., Rimm, B.S.A., Klein, J.P., Shuster, J.J., Sobocinski, K.A. & Gale, R.P. (1994) Bone marrow transplants from HLA identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. New England Journal of Medicine, 331, 1253-1258.
3. Bordigoni, P., Leverger, G. & Baruchel, A. (1996) Comparison between allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission. In: Acute Leukemias V (ed. by W. Hieldemann and T. Büchner), in press.
4. Bozdech, M.J., Sondel, P.M., Trigg, M.E., Longo, W., Kohler, P.C., Flynn, B., Billing, R., Anderson, S.A., Hank, J.A. & Hong, R. (1985) Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arobinoside to the pretransplant conditioning prevents rejection. Experimental Hematology, 13, 1201-1210.
5. Brochstein, J.A., Kernan, N.A., Groshen, S., Cirrincione, C., Shank, B., Emanuel, D., Laver, J. & O'Reilly, R.J. (1987) Allogeneic bone marrow transplantation after hyperfractionated total-body-irradiation and cyclophosphamide in children with acute leukemia. New England Journal of Medicine, 317, 1618-2363.
6. Casper, J., Comitta, B., Truitt, R., Baxter-Lowe, L.A., Bumin, N., Lawton, C., Murray, K., Hunter, J., Pietryga, D., Garbrecht, F., Keever Taylor, C., Drobyski, W., Horowitz, M., Flomenberg, N. & Ash, R. (1995) Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood, 85, 2354-2363.
7. Cavazzana-Calvo, M., Sarnacki, S., Haddad, E., De Coene, C., Calise, D., Yvon, E., Cerf-Bensussan, N. & Fischer, A. (1995) Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody. Transplantation, 59, 1576-1582.
8. Cavazzana-Calvo, M., Stephan, J.L., Sarnacki, S., Chevret, S., Fromont, C., De Coene, C., Le Deist, F., Guy-Grand, D. & Fischer, A. (1994) Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T-cells in an H-2 haplotype disparate mouse combination. Blood, 83, 288-298.
9. Chessels, J.M. (1992) Treatment of childhood acute lymphoblastic leukemia: present issues and future propects. Blood Reviews, 6, 193-200.
10. Clift, R., Buckner, C., Appelbaum, F., Bryant, E., Bearman, S.I., Petersen, F.B., Fischer, L.D., Anasetti, C., Beatty, P., Bensinger, W.I., Doney, K., Hill, R.S., McDonald, G.B., Martin, P., Meyers, J., Sanders, J., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R., Storb, R., Hansen, J.A. & Thomas, E.D. (1991) Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood, 77, 1660-1665.
11. Cobbold, S.P., Martin, G., Quin, S. & Waldman, H. (1986) Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature, 323, 164-166.
12. Dopier, R., Henze, G., Bender-Götze, C., Ebell, W., Ehninger, G., Friedrich, W., Gadner, H., Klingebiel, T., Peters, C., Riehm, H., Suttorp, M., Schmid, H., Schmitz, N., Siegert, W., Stollmann-Gibbels, B., Hartmann, R. & Niethammer, D. (1991) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood, 78, 2780-2784.
13. Drobyski, W.R., Asch, R.C., Casper, J.T., Mc Auliffe, T., Horowitz, M.M., Lawton, C., Keever, C., Baxter-Lowe, C.A., Camitta, B. Garbretch, F., Pietryga, D., Hansen, R., Chritambar, C.R., Anderson, T. & Flomenberg, N. (1994) Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood, 83, 1980-1987.
14. Fischer, A., Friedrich, W., Blanche, S., Le Deist, F., Fasth, A., Veber, F., Hirn, M., Frappaz, D., Gerota, I. & Griscelli, C. (1991) Reduction of graft failure by a monoclonal antibody (anti LFA-1 CD11a) after HLA non-identical bone marrow transplantation in children with inborn errors. Blood, 77, 249-256.
15. Glucksberg, H., Storb, R. & Fefer, A. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation, 18, 295-304.
16. Hale, G., Bright, S., Chumbley, G., Hoang, T., Metcalf, D., Munro, A.J. & Waldmann, H. (1983) Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood, 62, 873-882.
17. + T cells. European Journal of Immunology, 25, 2285-2294.
18. Henze, G., Fengler, R., Hartmann, R., Kornhuber, B., Jauka-Schaub, G., Niethammer, D. & Riemh, H. (1991) Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ-BFM 1985): a relapse study of the BFM group. Blood, 78, 1166-1172.
19. Hervé, P., Wijdenes, J., Bergerat, J.P., Bordigoni, P., Milpied, N., Cahn, J.Y., Clement, C., Beliard, R., Morel-Fourrier, B., Racadot, E., Troussard, X., Benz-Lemoine, E., Gaud, C., Legros, M., Attal, M., Kpoft, M. & Peters, A. (1990) Treatment of corticosteroids resistant acute GVHD by in vivo administration of anti-IL-2 receptor monoclonal antibody (B-B10). Blood, 75, 1017-1023.
20. Jabado, N., Le Deist, F., Cant, A., De Graeff-Meeders', E.R., Fasth, A., Morgan, G., Vellodi, A., Hale, G., Bujan, W., Thomas, C., Cavazzana-Calvo, M., Wijdenes, J. & Fischer, A. (1996) Bone marrow transplantation from genetically HLA-non-identical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Pediatrics, in press.
21. Kalbfeisch, J.D. & Prentice, R.L. (1980) The Statistical Analysis of Failure Time Data. Wiley, New York.
22. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimations for incomplete observation. Journal of the American Statistical Association, 53, 457-460.
23. Kernan, N.A., Bartsch, G., Ash, R.C., Beatty, P.G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A., Henslee-Downey, J., Mc Cullogh, J., Mc Glave, P., Perkins, H.A., Phillips, L., Sanders, J., Stroncek, D., Thomas, E.D. & Blume, K.G. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. New England Journal of Medicine, 328, 593-602.
24. Krensky, A.M., Robbins, E., Springer, T.A. & Burakoff, S.J. (1984) LFA-1, LFA-2 and LFA-3 antigens are involved in CTL-target conjugation. Journal of Immunology, 132, 2180-2184.
25. Lapidot, T., Singer, T.S., Salomon, O., Terenzi, A. Schwartz, E. & Reisner, Y. (1988) Booster irradiation to the spleen following total body irradiation: a new immunosuppressive approach for allogeneic bone marrow transplantation. Journal of Immunology, 141, 2619-2624.
26. Nakahori, Y., Mitani, K., Yamada, M. & Nakagome, Y. (1986) A human chromosome specific repeated DNA family (DY21) consists of a tandem assay of pentanucleatides. Nucleic Acids Research, 14, 7569-7574.
27. Papadopoulos, E.B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M.H., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Small, T.N., Young, J.W., Kernan, N.A. & O'Reilly, R.J. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New England Journal of Medicine, 330, 1185-1192.
28. Perez, N., LeDeist, F., Chatenoud, L., Chanteloup, N. & Fischer, A. (1989) In vivo infusions of anti-LFA-1 antibody in HLA non-identical bone marrow transplantation and biological effects. Hone Marrow Transplantation, 4, 379-384.
29. Qin, L., Chavin, K.D., Lin, J., Yagita, H. & Bromberg, J.S. (1994) Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. Journal of Experimental Medicine, 179, 341-346.
30. Reisner, Y., Itziconitch, L., Meshorer, A. & Sharon, N. (1978) Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proceedings of the National Academy of Sciences of the United States of America, 75, 2933-2936.
31. Reisner, Y., Kapoor, N., Kirkpatrick, D., Pollack, M.S., Cunningham-Rundles, S., Dupont, B., Hodes, M.Z., Good, R.A. & O'Reilly, R.J. (1983) Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean lectin aggentinin and sheep red blood cells. Blood, 61, 341-348.
32. Rivera, G.K., Raimondi, S.C., Hancock, M.L., Behm, F.G., Pui, C.H., Abromowitch, M., Mirro, J., Ochs, J., Look, A.T., Williams, D.L., Murphy, S.B., Dahl, G.V., Kalwinsky, D.K., Evans, W.E., Kun, L.E., Simone, J.V. & Crist, W.M. (1991) Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet, 337, 61-66.
33. Rooney, C.M., Smith, C.A., Ng, C.Y.C., Loftin, S., Li, C., Krance, R.A & Brenner, M.K. (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus related lymphoproliferation. Lancet, 345, 9-13.
34. Sanchez-Madrid, F., Krensky, A.M., Ware, C.F., Robbins, E., Strominger, J.L., Burakoff, S.J. & Springer, T.A. (1982) Three distinct antigens associated with human T-lymphocyte mediated cytolysis: LFA-1, LFA-2 and LFA-3. Proceedings of the National Academy of Sciences of the United States of America, 79, 7489-7493.
35. Schwartz, E., Lapidot, T., Dali, G., Singer, T. & Reisner, Y. (1987) Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors. Journal of Immunology, 138, 460-465.
36. Shaw, S., Luce, G.E.G., Quinones, R., Gress, R.E. & Springer, T.A. (1986) Two antigen-independent adhesion pathways used by human cytotoxicity cell clones. Nature, 323, 262-264.
37. Socie, G., Landman, J., Gluckman, E., Devergie, A., Raynal, B., Esperou, H. & Brison, O. (1992) Short-term study of chimaerism after bone marrow transplantation for severe aplastic anaemia. British Journal of Haematology, 80, 391-398.
38. Soiffer, R.J., Mauch, P., Tarbell, N.J., Anderson, K.C., Freedman, A.S., Rabinowe, S.N., Takuorian, T., Murrey, C.I., Coral, F., Bosserman, L., Dear, K., Nadler, L.M. & Ritz, J. (1991) Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow. Bone Marrow Transplantation, 7, 23-33.
39. Springer, T.A. (1990) Adhesion receptors of the immune system. Nature, 346, 425-434.
40. Steinherz, P., Meyers, P., Wollner, N., Redner, A. & Tan, C. (1989) Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood. Cancer, 63, 1472-1476.
41. Thomas, C., Le Deist, F., Cavazzana-Calvo, M., Benkerrou, M., Haddad, E., Blanche, S., Hartamann, W., Friedrich, W. & Fischer, A. (1995) Bone marrow transplantation for the treatment of the children with leucocyte adhesion deficiency: a review of 14 cases. Blood, 86, 1629-1635.
42. Tiberghien, P., Reynolds, C.W., Keller, J., Spence, S., Deschaseaux, M., Gertoux, J.M., Coutassot, E., Murphy, W.J., Lyons, R., Chiang, Y., Hervé, P., Longo, D.L. & Ruscetti, F.W. (1994) Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation. Blood, 84, 1333-1341.
43. Van Dijken, P.J., Ghayur, T., Mauch, P., Down, J., Burakoff, S.J. & Ferrara, L.M. (1990) Evidence that an anti-LFA-1 in vivo improves engraftment and survival after allogeneic bone marrow transplantation. Transplantation, 49, 822-886.